GEn1E Lifesciences Inc.

I am deeply honored and thrilled to share that I have?been appointed?Affiliate Associate Professor in the Department of Pharmaceutical Sciences (PSC), at the University of Maryland, Baltimore (UMB) Pharmaceutical Sci UMSOP School of Pharmacy?— my beloved alma mater where I completed my PhD loooooong ago (you can tell that from one of my photo below). I am sincerely grateful for the opportunity?to contribute to the community that has been instrumental in shaping my professional journey. At GEn1E Lifesciences Inc., we are driving innovation through strong collaboration with Dr. Jeffrey Hasday, Dr. Paul Shapiro and a team of remarkable researchers. This is along with the amazing team at the @Office of Technology Transfer at University of Maryland, Baltimore (UMB) which has been instrumental in aligning academia and industry goals to accelerate novel medicines for patients. In this new role, I am looking forward to engaging with fellow faculty members, researchers and the students who are the future #pharmapreneurs! I want to extend my gratitude to all my mentors and the academic community at UMB for your unwavering support. My heartfelt thanks to Dr. Paul Shapiro for nominating,?Dr. Hongbing Wang, interim chair of the department for recommending, and?Dr. Sarah Michel,?Dean and Professor?for appointing me. Here’s to new beginnings, continued innovation, and developing novel therapies for patients together! #Thankyou #ProudAlumni #Biotech #Innovation #DreamComeTrue #GEn1E #NextGen #Immunology #Inflammation #ARDS #AI #Immunomodulators #DualSignalModulators

The GEn1E team had an amazing week at the 5th Respiratory Innovation Summit (RIS) followed by American Thoracic Society in San Diego. A heartfelt thank you to the RIS organizers (Timothy Watkins, MD MSc, Sarah Spencer, Michelle Turenne, Dustin Bell, PMP) for orchestrating such a remarkable event?with terrific participation from government organizations, patient groups (thank you Paula Blonski), physicians, biopharmas, industry leaders, entrepreneurs, investors, with insightful discussions and valuable networking opportunities. And for providing GEn1E Lifesciences Inc. the platform to present to this amazing audience. My heartfelt gratitude and a very special shout-out to?Michelle Turenne?and Dustin Bell, PMP whose stellar support made this event a resounding success for GEn1E. Immediately following RIS was ATS with terrific reception to groundbreaking research and scientific posters by Mohan Tulapurkar, Jeffrey Hasday, Paul Shapiro, Alexander MacKerell, Steven Fletcher where we presented the mechanism of action of our novel compounds. This was an invaluable opportunity to connect and riff with thought leaders and fellow professionals in the field. And in addition to these awesome events, our team also got a chance to present our prospective Machine Learning model for the identification of Acute Respiratory Distress Syndrome (ARDS) sub-phenotypes. This precision health approach helps to identify ARDS endotypes using readily-available clinical parameters without the use of specialized biomarkers. What this enables is the mapping in real-time of disease trajectories longitudinally using routinely collected parameters as well as the understanding of transition probabilities between the endotypes. More to follow??on this topic. Please stay tuned! A big and heartfelt thank you also to our Phase 2 study collaborators and partners for making the time to connect at ATS and we look forward to working closely with you. Thank you everyone for making this event so productive and memorable for us! Can’t wait for the next RIS and ATS 2025 right here in the Bay Area! #ATS2024 #RIS2024 #ThankYou #Gratitude #PulmonaryResearch #RespiratoryHealth #Innovation #Collaboration #ARDS #DualSignalModulators #PrecisionTherapies?#Endotyping #AI #ML

We are honored and thrilled to announce that our submission has been selected for a featured showcase presentation at the 2024 Respiratory Innovation Summit hosted by the American Thoracic Society (ATS)! ?? ?? This summit unites innovators, investors, clinicians, and advocacy groups who are leading the charge to create powerful new treatments for deadly and crippling diseases of the lungs and airways. We are honored to have this opportunity to share our ideas and collaborate with like-minded experts. The summit will be held in San Diego, California on Friday, May 17 and Saturday, May 18. We are looking forward to meeting our present and future collaborators at this amazing event. We extend our heartfelt thanks to the organizers of RIS and American Thoracic Society for this fantastic opportunity as we continue to accelerate the development of our novel, dual modulation therapies to improve respiratory health! ?? ?? ? #RIS2024 #InspireInnovation #ards #pulmonary #respiratory #dualsignalmodulators #ATS #immunomodulators #precisiontherapies #AI #ML #drugdevelopment

I am thrilled to share that I have been appointed as Adjunct Professor in the Department of Pharmaceutics and Medicinal Chemistry at University of the Pacific - Thomas J. Long School of Pharmacy. It is an incredible honor for me to be recognized by such an esteemed institution, and I am truly grateful for this opportunity. ???? During my first class, I had an amazing opportunity to engage with the students and was impressed by their thoughtful questions about drug development and other topics which we work with on a daily basis at GEn1E Lifesciences Inc.. I gained valuable insights from our discussion, and I am excited to continue contributing to the university and interacting with the student community. I would like to express my heartfelt gratitude to Miki Park and Krishna Devarakonda, as well as the university's leadership, for this gracious opportunity. It is a privilege to be a part of your institution, and I look forward to making a meaningful impact in my role as Adjunct Professor. #heartfelt #thankyou #adjunctprofessor #drugdevelopment #AI #ML

GEn1E Lifesciences Inc. was recognized as one of "Palo Alto's top Biotechnology companies"! The companies recognized are at the forefront of innovation and making exceptional strides in the field of #biotech. Congratulations to the GEn1E team and founder Ritu Lal, Ph.D., M.S. (Management) on your achievements and dedication to advancing health science! ?? #HealthScience #PaloAlto #Innovation #Startup